Angiotensin II receptor (AT1) antagonists in heart failure after Val-HeFT--Quo Vadis?
Giles
T D
TD
LSUMC Health Sciences Center, New Orleans, LA, USA.
Sander
G E
GE
D000368:Aged; D057911:Angiotensin Receptor Antagonists; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome
D057911:Angiotensin Receptor Antagonists; D002317:Cardiovascular Agents